ArticleJMIR AI2026
AI-Powered Framework for Personalized Prescription of Physical Activity in Aging: Proposing PEPHA, a framework for Personalized Phenotyping for Aging.
Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Personalizing physical activity recommendations for older adults requires understanding not only which dimensions of physical activity and sedentary behaviors (24-h movement behaviors) influence health outcomes but also when, within an individual's everyday life, these dimensions are most relevant. Current observational and interventional approaches rarely capture the temporal dynamics linking everyday patterns of 24-hour movement behaviors to cognitive and mental health trajectories, 2 key determinants of healthy aging. Objective: This study introduces and evaluates PEPHA (Personalized Phenotyping for Aging), an interpretable artificial intelligence (AI) framework designed to identify which dimensions of behavior and when within an observation window are strongly associated with cognitive functioning and depressive symptoms in older adults. Methods: We introduce PEPHA, an interpretable AI framework that integrates passive, high-frequency wearable data (physical activity and sleep) with periodic, active, validated cognitive and affective assessments (waves). Using longitudinal data from the Results: Personalized analyses showed that roughly 40% of individuals exhibited moderate or large temporal order effects of 24-hour movement behavior in the outcomes. For 1 exemplar participant (male, above the mean sample age), we localized 2 potential temporal association windows approximately 60 days and 30 days before the assessment of his processing speed, suggesting periods during which this individual may have been more sensitive to favorable or unfavorable behavioral configurations. Across participants, PEPHA revealed distinct 24-hour movement behavioral patterns correlated with cognitive functioning and mental health. Processing speed was best explained by locomotor activity, while depressive symptoms were best explained by sedentary behavior. Five control variables (education, cognitive reserve, diet, sex, and subjective age difference) were noninformative, whereas chronological age had predictive power regarding depressive symptoms. Conclusions: PEPHA demonstrates that continuous passive wearable data can uncover individualized, time-specific behavioral patterns associated with cognitive functioning and mental health. Although exploratory, this framework transforms observational data into interpretable, timing-aware insights that can help identify periods of increased behavioral sensitivity or association, thereby informing future personalized, AI-supported physical activity interventions in aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.